MARKSANS PHARMA
Back to Cashflow Statement
|
MARKSANS PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹207 Cr | ₹230 Cr | ₹237 Cr | ₹99 Cr | ₹179 Cr |
What is the latest Cash Flow from Operating Activities ratio of MARKSANS PHARMA ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2025 | ₹207 Cr |
Mar2024 | ₹230 Cr |
Mar2023 | ₹237 Cr |
Mar2022 | ₹99 Cr |
Mar2021 | ₹179 Cr |
How is Cash Flow from Operating Activities of MARKSANS PHARMA Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2025 | ₹207 Cr | -10.30 | |
Mar2024 | ₹230 Cr | -2.95 | |
Mar2023 | ₹237 Cr | 139.19 | |
Mar2022 | ₹99 Cr | -44.42 | |
Mar2021 | ₹179 Cr | - |
Compare Cash Flow from Operating Activities of peers of MARKSANS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MARKSANS PHARMA | ₹11,588.3 Cr | -2% | 3.3% | 37.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,267.0 Cr | 0.7% | 2.8% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,672.0 Cr | -0.8% | 3.7% | 48.6% | Stock Analytics | |
CIPLA | ₹119,713.0 Cr | -0.2% | -0.1% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,195.0 Cr | 3.4% | 11.2% | 17.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,999.0 Cr | 0.6% | -5.2% | -4.9% | Stock Analytics |
MARKSANS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MARKSANS PHARMA | -2% |
3.3% |
37.9% |
SENSEX | -0.9% |
0.4% |
1.4% |
You may also like the below Video Courses